TickerTalks
Browse all tickers →
TickerTalks›$GEHC
GEGEHC

GE HealthCare Technologies Inc.

$GEHC·$32B·Medical - Healthcare Information Services·Healthcare
$68.02-2.7%YTD-15.3%1Y-4.6%
Mentions · last 7 days
2026-07-24: 25 posts2026-07-25: 30 posts2026-07-26: 27 posts2026-07-27: 30 posts2026-07-28: 42 posts2026-07-29: 169 posts2026-07-30: 59 posts384
Price updated 5h ago·X counts updated 1d ago
GEGEHC
$GEHCGE HealthCare Technologies Inc.
$68.02-2.75%384 posts
AI analysisFundamentalsVoices on X
Loading…

Sentiment on XAI analysisGenerated by AI from underlying data

Top X posts

How loud the X conversation is around $GEHC and which way it's leaning — read in seconds.

X sentiment

What the X crowd is saying right now — descriptive, summarised from the day’s posts.

Bullish sentiment13 posts analyzed · as of 2026-07-31

GE HealthCare beat and reaffirmed. Q2 adjusted EPS $1.13 vs $1.04 consensus on $5.3B revenue (a $40M beat), with full-year EPS guide reaffirmed at $4.80-$5.00 matching Street. Management called out increased orders and healthy demand across segments, and tariff refunds helped offset one-offs. Stock printed +10-11% pre-market. GEHC keeps appearing on 'stocks on my radar' shortlists alongside MSFT and INTU as an enterprise-quality Q2 winner. No bear voice.

Read what X is saying about $GEHC

  • Bullish vs bearish call — with the AI summary of the day's posts
  • Divergence flag when the top-engagement posts argue the other side
  • Volume context so you know if today's chatter is normal or unusual
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.

Industry overviewAI analysisGenerated by AI from underlying data

Where Medical - Healthcare Information Services sits in its cycle right now — and what that implies for $GEHC.

Medical - Healthcare Information Services · Healthcare

No material change from last week — VEEV's 'agentic commercial' CRM framing converts AI from feature to platform pricing, while TEM's oncology AI platform and pharma data licensing confirm AI..

Industry benchmark

9-name peer basket
+37.6%YTD
+43.4%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
20.1How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
8.1%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
12.7%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
2.8%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
1.6Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
15.2%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
42.9%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.9Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q2 2026Jul 29, 2026$1.13$1.04+8.7%
Q1 2026Apr 29, 2026$0.99$1.04-4.8%
Q4 2025Feb 4, 2026$1.44$1.40+2.9%
Q3 2025Oct 29, 2025$1.07$1.05+1.9%
Next earningsWed, Nov 4·consensus EPS $1.22

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q2 FY26$5.3B+5.8%41.2%14.0%$1.24$-617.0M
Q1 FY26$5.1B+7.4%38.5%10.0%$0.85$112.0M
Q4 FY25$4.7B-12.1%54.3%14.2%$0.41$917.0M
Q3 FY25$5.1B+5.8%38.7%12.7%$0.98$483.0M

Forward consensus

5-year forecast · up to 16 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$21.8B$21.6B – $21.9B$4.90$4.87 – $4.9114
FY27$22.8B$22.5B – $22.9B$5.42$5.19 – $5.5414
FY28$23.9B$23.3B – $24.4B$6.04$5.57 – $6.4416
FY29$25.1B$24.8B – $25.4B$6.68$6.56 – $6.7815
FY30$26.1B$25.8B – $26.4B$7.31$7.18 – $7.4215

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.1.3×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.36%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+9.4%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.-4.3%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatHigh float · 453.4M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today1.7% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.845-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

BuyMay 22Kevin LoboDirector10.0K sh$642KBuyMay 12Rodney F HochmanDirector1.6K sh$100KBuyMay 8Yang Watkin Phoebe L.Director1.0K sh$63KBuyMay 6Culp H Lawrence JrDirector80.8K sh$5.0MBuyMay 6William J StrombergDirector1.0K sh$62KBuyMay 1James SaccaroCFO3.3K sh$201KBuyApr 30Frank R JimenezGC & Corporate Secretary1.8K sh$106KBuyApr 30Peter J ArduiniCEO4.2K sh$250K
+ 20 other (19 awards · 1 inkind) in window

See when $GEHC insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigationprnewswire.com·14h agoSecurities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Figurufocus.com·15h agoSecurities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firmprnewswire.com·16h agoSecurities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruzgurufocus.com·1d agoSecurities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruzprnewswire.com·1d ago

In themes

Explore the broader themes this ticker is being talked about under.

AI Precision Medicine

More in Medical - Healthcare Information Services

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$TEM$TDOC$BTSG$TXG$PGNY$HCAT$WGS$AMWL
Voices on X · top 13 · last 7 days

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport